nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—bipolar disorder—Topiramate—obesity	0.265	1	CpDpCtD
Risperidone—DRD4—obesity	0.0581	0.221	CbGaD
Risperidone—HTR1B—obesity	0.0516	0.197	CbGaD
Risperidone—DRD1—obesity	0.0492	0.187	CbGaD
Risperidone—HTR2C—obesity	0.0421	0.16	CbGaD
Risperidone—DRD2—obesity	0.0347	0.132	CbGaD
Risperidone—ADRA1B—Phendimetrazine—obesity	0.0294	0.108	CbGbCtD
Risperidone—HTR2A—obesity	0.0268	0.102	CbGaD
Risperidone—DRD1—Phenylpropanolamine—obesity	0.0265	0.0971	CbGbCtD
Risperidone—ADRA1A—Phendimetrazine—obesity	0.0232	0.085	CbGbCtD
Risperidone—ADRA2C—Methamphetamine—obesity	0.0222	0.0814	CbGbCtD
Risperidone—ADRA2B—Methamphetamine—obesity	0.0211	0.0772	CbGbCtD
Risperidone—ADRA2A—Benzphetamine—obesity	0.0183	0.0672	CbGbCtD
Risperidone—ADRA1A—Benzphetamine—obesity	0.0176	0.0644	CbGbCtD
Risperidone—ADRA2A—Phenylpropanolamine—obesity	0.0175	0.0641	CbGbCtD
Risperidone—ADRA1A—Phenylpropanolamine—obesity	0.0168	0.0614	CbGbCtD
Risperidone—ADRA2A—Methamphetamine—obesity	0.0146	0.0537	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Cimetidine—obesity	0.00827	0.0303	CbGbCtD
Risperidone—CYP3A7—Cimetidine—obesity	0.00827	0.0303	CbGbCtD
Risperidone—CYP3A5—Cimetidine—obesity	0.0062	0.0227	CbGbCtD
Risperidone—CYP2D6—Phentermine—obesity	0.00609	0.0223	CbGbCtD
Risperidone—CYP2D6—Bupropion—obesity	0.00518	0.019	CbGbCtD
Risperidone—CYP3A4—Sibutramine—obesity	0.00511	0.0187	CbGbCtD
Risperidone—CYP2D6—Methamphetamine—obesity	0.00487	0.0179	CbGbCtD
Risperidone—ABCB1—Cimetidine—obesity	0.00404	0.0148	CbGbCtD
Risperidone—CYP3A4—Benzphetamine—obesity	0.00387	0.0142	CbGbCtD
Risperidone—CYP2D6—Cimetidine—obesity	0.0038	0.0139	CbGbCtD
Risperidone—CYP3A4—Bupropion—obesity	0.00329	0.0121	CbGbCtD
Risperidone—CYP3A4—Orlistat—obesity	0.00269	0.00985	CbGbCtD
Risperidone—CYP3A4—Cimetidine—obesity	0.00242	0.00887	CbGbCtD
Risperidone—CYP3A4—Topiramate—obesity	0.00158	0.0058	CbGbCtD
Risperidone—HTR7—sympathetic nervous system—obesity	0.00138	0.0653	CbGeAlD
Risperidone—HTR7—vagus nerve—obesity	0.00134	0.0633	CbGeAlD
Risperidone—HTR7—autonomic nervous system—obesity	0.000928	0.0439	CbGeAlD
Risperidone—HTR2A—sympathetic nervous system—obesity	0.000861	0.0407	CbGeAlD
Risperidone—HTR2A—vagus nerve—obesity	0.000834	0.0395	CbGeAlD
Risperidone—HTR2A—autonomic nervous system—obesity	0.000579	0.0274	CbGeAlD
Risperidone—H1F0—islet of Langerhans—obesity	0.00041	0.0194	CbGeAlD
Risperidone—HTR1A—hindbrain—obesity	0.000409	0.0194	CbGeAlD
Risperidone—HTR7—hindbrain—obesity	0.000391	0.0185	CbGeAlD
Risperidone—H1F0—respiratory system—obesity	0.000387	0.0183	CbGeAlD
Risperidone—ADRA1A—hindbrain—obesity	0.000377	0.0178	CbGeAlD
Risperidone—DRD2—hindbrain—obesity	0.00037	0.0175	CbGeAlD
Risperidone—H1F0—adrenal cortex—obesity	0.000325	0.0154	CbGeAlD
Risperidone—Paliperidone—DRD4—obesity	0.000308	0.134	CrCbGaD
Risperidone—H1F0—cardiovascular system—obesity	0.000296	0.014	CbGeAlD
Risperidone—CYP3A7—endocrine gland—obesity	0.000274	0.013	CbGeAlD
Risperidone—Paliperidone—HTR1B—obesity	0.000274	0.119	CrCbGaD
Risperidone—H1F0—pituitary gland—obesity	0.000262	0.0124	CbGeAlD
Risperidone—H1F0—adipose tissue—obesity	0.000261	0.0124	CbGeAlD
Risperidone—Paliperidone—DRD1—obesity	0.000261	0.113	CrCbGaD
Risperidone—CYP3A7—liver—obesity	0.000247	0.0117	CbGeAlD
Risperidone—H1F0—digestive system—obesity	0.000246	0.0116	CbGeAlD
Risperidone—HTR2A—hindbrain—obesity	0.000244	0.0115	CbGeAlD
Risperidone—HTR7—respiratory system—obesity	0.000239	0.0113	CbGeAlD
Risperidone—HTR1B—cardiovascular system—obesity	0.000237	0.0112	CbGeAlD
Risperidone—KCNH2—islet of Langerhans—obesity	0.000236	0.0111	CbGeAlD
Risperidone—H1F0—adrenal gland—obesity	0.000234	0.0111	CbGeAlD
Risperidone—HTR2B—adrenal cortex—obesity	0.000234	0.0111	CbGeAlD
Risperidone—HTR1D—cardiovascular system—obesity	0.00023	0.0109	CbGeAlD
Risperidone—DRD2—respiratory system—obesity	0.000226	0.0107	CbGeAlD
Risperidone—Paliperidone—HTR2C—obesity	0.000223	0.0971	CrCbGaD
Risperidone—CYP2D6—hindbrain—obesity	0.000222	0.0105	CbGeAlD
Risperidone—Iloperidone—DRD4—obesity	0.000216	0.0938	CrCbGaD
Risperidone—HTR2B—cardiovascular system—obesity	0.000214	0.0101	CbGeAlD
Risperidone—CYP3A7-CYP3A51P—liver—obesity	0.00021	0.00995	CbGeAlD
Risperidone—H1F0—endocrine gland—obesity	0.000203	0.00962	CbGeAlD
Risperidone—CYP3A5—islet of Langerhans—obesity	0.000195	0.00921	CbGeAlD
Risperidone—HTR1A—cardiovascular system—obesity	0.000191	0.00906	CbGeAlD
Risperidone—HTR2B—adipose tissue—obesity	0.000188	0.00891	CbGeAlD
Risperidone—ADRA2A—islet of Langerhans—obesity	0.000185	0.00878	CbGeAlD
Risperidone—ADRA2C—adrenal cortex—obesity	0.000184	0.00872	CbGeAlD
Risperidone—Paliperidone—DRD2—obesity	0.000184	0.08	CrCbGaD
Risperidone—CYP3A5—respiratory system—obesity	0.000184	0.00869	CbGeAlD
Risperidone—H1F0—liver—obesity	0.000183	0.00867	CbGeAlD
Risperidone—HTR7—cardiovascular system—obesity	0.000183	0.00865	CbGeAlD
Risperidone—Iloperidone—DRD1—obesity	0.000182	0.0794	CrCbGaD
Risperidone—HRH1—respiratory system—obesity	0.000178	0.00844	CbGeAlD
Risperidone—HTR2B—digestive system—obesity	0.000177	0.00839	CbGeAlD
Risperidone—ADRA1A—cardiovascular system—obesity	0.000176	0.00835	CbGeAlD
Risperidone—KCNH2—cardiovascular system—obesity	0.00017	0.00806	CbGeAlD
Risperidone—HTR2B—adrenal gland—obesity	0.000169	0.00799	CbGeAlD
Risperidone—HTR1B—endocrine gland—obesity	0.000163	0.0077	CbGeAlD
Risperidone—Iloperidone—HTR2C—obesity	0.000156	0.0679	CrCbGaD
Risperidone—ADRA1A—adipose tissue—obesity	0.000156	0.00736	CbGeAlD
Risperidone—DRD2—pituitary gland—obesity	0.000153	0.00725	CbGeAlD
Risperidone—HTR7—digestive system—obesity	0.000152	0.00718	CbGeAlD
Risperidone—HTR1A—adrenal gland—obesity	0.000151	0.00716	CbGeAlD
Risperidone—KCNH2—pituitary gland—obesity	0.000151	0.00714	CbGeAlD
Risperidone—HTR2A—respiratory system—obesity	0.000149	0.00705	CbGeAlD
Risperidone—ADRA2C—pituitary gland—obesity	0.000149	0.00704	CbGeAlD
Risperidone—ADRA2C—adipose tissue—obesity	0.000148	0.00701	CbGeAlD
Risperidone—HTR7—adrenal gland—obesity	0.000145	0.00685	CbGeAlD
Risperidone—Paliperidone—HTR2A—obesity	0.000142	0.0618	CrCbGaD
Risperidone—ADRA1A—adrenal gland—obesity	0.00014	0.0066	CbGeAlD
Risperidone—KCNH2—adrenal gland—obesity	0.000135	0.00638	CbGeAlD
Risperidone—ADRA2C—adrenal gland—obesity	0.000133	0.00629	CbGeAlD
Risperidone—HTR1A—endocrine gland—obesity	0.000131	0.00621	CbGeAlD
Risperidone—Iloperidone—DRD2—obesity	0.000129	0.056	CrCbGaD
Risperidone—HTR7—endocrine gland—obesity	0.000125	0.00594	CbGeAlD
Risperidone—CYP3A5—adipose tissue—obesity	0.000124	0.00587	CbGeAlD
Risperidone—Iloperidone—CYP2E1—obesity	0.000124	0.0539	CrCbGaD
Risperidone—ADRA1A—endocrine gland—obesity	0.000121	0.00573	CbGeAlD
Risperidone—HRH1—adipose tissue—obesity	0.00012	0.0057	CbGeAlD
Risperidone—ADRA2A—pituitary gland—obesity	0.000119	0.00562	CbGeAlD
Risperidone—DRD2—endocrine gland—obesity	0.000119	0.00561	CbGeAlD
Risperidone—ADRA2A—adipose tissue—obesity	0.000118	0.0056	CbGeAlD
Risperidone—KCNH2—endocrine gland—obesity	0.000117	0.00553	CbGeAlD
Risperidone—CYP3A5—digestive system—obesity	0.000117	0.00553	CbGeAlD
Risperidone—HTR2A—cardiovascular system—obesity	0.000114	0.0054	CbGeAlD
Risperidone—HRH1—digestive system—obesity	0.000113	0.00536	CbGeAlD
Risperidone—HTR7—liver—obesity	0.000113	0.00535	CbGeAlD
Risperidone—ADRA1A—liver—obesity	0.000109	0.00516	CbGeAlD
Risperidone—HRH1—adrenal gland—obesity	0.000108	0.00511	CbGeAlD
Risperidone—ADRA2A—adrenal gland—obesity	0.000106	0.00502	CbGeAlD
Risperidone—ADRA2C—liver—obesity	0.000104	0.00492	CbGeAlD
Risperidone—ABCB1—islet of Langerhans—obesity	0.000103	0.00489	CbGeAlD
Risperidone—HTR2A—pituitary gland—obesity	0.000101	0.00478	CbGeAlD
Risperidone—Iloperidone—HTR2A—obesity	9.94e-05	0.0432	CrCbGaD
Risperidone—ABCB1—respiratory system—obesity	9.76e-05	0.00462	CbGeAlD
Risperidone—CYP3A5—endocrine gland—obesity	9.65e-05	0.00457	CbGeAlD
Risperidone—HTR2A—digestive system—obesity	9.47e-05	0.00448	CbGeAlD
Risperidone—HRH1—endocrine gland—obesity	9.37e-05	0.00443	CbGeAlD
Risperidone—ADRA2A—endocrine gland—obesity	9.2e-05	0.00435	CbGeAlD
Risperidone—HTR2A—adrenal gland—obesity	9.02e-05	0.00427	CbGeAlD
Risperidone—CYP3A4—digestive system—obesity	8.76e-05	0.00415	CbGeAlD
Risperidone—CYP3A5—liver—obesity	8.7e-05	0.00412	CbGeAlD
Risperidone—CYP2D6—digestive system—obesity	8.62e-05	0.00408	CbGeAlD
Risperidone—ABCB1—adrenal cortex—obesity	8.19e-05	0.00388	CbGeAlD
Risperidone—HTR2A—endocrine gland—obesity	7.82e-05	0.0037	CbGeAlD
Risperidone—ABCB1—cardiovascular system—obesity	7.47e-05	0.00354	CbGeAlD
Risperidone—CYP3A4—endocrine gland—obesity	7.24e-05	0.00343	CbGeAlD
Risperidone—CYP2D6—endocrine gland—obesity	7.13e-05	0.00337	CbGeAlD
Risperidone—HTR2A—liver—obesity	7.05e-05	0.00334	CbGeAlD
Risperidone—ABCB1—pituitary gland—obesity	6.62e-05	0.00313	CbGeAlD
Risperidone—ABCB1—adipose tissue—obesity	6.59e-05	0.00312	CbGeAlD
Risperidone—CYP3A4—liver—obesity	6.53e-05	0.00309	CbGeAlD
Risperidone—CYP2D6—liver—obesity	6.42e-05	0.00304	CbGeAlD
Risperidone—ABCB1—digestive system—obesity	6.2e-05	0.00294	CbGeAlD
Risperidone—ABCB1—adrenal gland—obesity	5.91e-05	0.0028	CbGeAlD
Risperidone—ABCB1—endocrine gland—obesity	5.13e-05	0.00243	CbGeAlD
Risperidone—ABCB1—liver—obesity	4.62e-05	0.00219	CbGeAlD
Risperidone—Infection—Orlistat—obesity	3.27e-05	0.00032	CcSEcCtD
Risperidone—Breast disorder—Topiramate—obesity	3.26e-05	0.000318	CcSEcCtD
Risperidone—Dry mouth—Sibutramine—obesity	3.25e-05	0.000318	CcSEcCtD
Risperidone—Aspartate aminotransferase increased—Topiramate—obesity	3.25e-05	0.000317	CcSEcCtD
Risperidone—Nervous system disorder—Orlistat—obesity	3.23e-05	0.000316	CcSEcCtD
Risperidone—Nasopharyngitis—Topiramate—obesity	3.22e-05	0.000315	CcSEcCtD
Risperidone—Confusional state—Sibutramine—obesity	3.22e-05	0.000314	CcSEcCtD
Risperidone—Vision blurred—Bupropion—obesity	3.21e-05	0.000314	CcSEcCtD
Risperidone—Skin disorder—Orlistat—obesity	3.2e-05	0.000313	CcSEcCtD
Risperidone—Tremor—Bupropion—obesity	3.19e-05	0.000312	CcSEcCtD
Risperidone—Gastritis—Topiramate—obesity	3.19e-05	0.000312	CcSEcCtD
Risperidone—Anaphylactic shock—Sibutramine—obesity	3.19e-05	0.000312	CcSEcCtD
Risperidone—Oedema—Sibutramine—obesity	3.19e-05	0.000312	CcSEcCtD
Risperidone—Hyperhidrosis—Orlistat—obesity	3.19e-05	0.000311	CcSEcCtD
Risperidone—Muscular weakness—Topiramate—obesity	3.18e-05	0.000311	CcSEcCtD
Risperidone—Alanine aminotransferase increased—Topiramate—obesity	3.18e-05	0.000311	CcSEcCtD
Risperidone—Infection—Sibutramine—obesity	3.17e-05	0.00031	CcSEcCtD
Risperidone—Ill-defined disorder—Bupropion—obesity	3.16e-05	0.000309	CcSEcCtD
Risperidone—Anaemia—Bupropion—obesity	3.15e-05	0.000308	CcSEcCtD
Risperidone—Shock—Sibutramine—obesity	3.14e-05	0.000307	CcSEcCtD
Risperidone—Abdominal distension—Topiramate—obesity	3.14e-05	0.000306	CcSEcCtD
Risperidone—Agitation—Bupropion—obesity	3.13e-05	0.000306	CcSEcCtD
Risperidone—Thrombocytopenia—Sibutramine—obesity	3.12e-05	0.000305	CcSEcCtD
Risperidone—Asthma—Topiramate—obesity	3.11e-05	0.000304	CcSEcCtD
Risperidone—Dysphagia—Topiramate—obesity	3.11e-05	0.000304	CcSEcCtD
Risperidone—Angioedema—Bupropion—obesity	3.11e-05	0.000304	CcSEcCtD
Risperidone—Tachycardia—Sibutramine—obesity	3.11e-05	0.000304	CcSEcCtD
Risperidone—Skin disorder—Sibutramine—obesity	3.1e-05	0.000303	CcSEcCtD
Risperidone—Hyperhidrosis—Sibutramine—obesity	3.08e-05	0.000301	CcSEcCtD
Risperidone—Malaise—Bupropion—obesity	3.07e-05	0.0003	CcSEcCtD
Risperidone—Vertigo—Bupropion—obesity	3.06e-05	0.000299	CcSEcCtD
Risperidone—Syncope—Bupropion—obesity	3.05e-05	0.000299	CcSEcCtD
Risperidone—Pancreatitis—Topiramate—obesity	3.05e-05	0.000298	CcSEcCtD
Risperidone—Leukopenia—Bupropion—obesity	3.05e-05	0.000298	CcSEcCtD
Risperidone—Anorexia—Sibutramine—obesity	3.04e-05	0.000297	CcSEcCtD
Risperidone—Sweating increased—Topiramate—obesity	3.03e-05	0.000297	CcSEcCtD
Risperidone—Angina pectoris—Topiramate—obesity	3.03e-05	0.000297	CcSEcCtD
Risperidone—Palpitations—Bupropion—obesity	3.01e-05	0.000294	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Orlistat—obesity	3e-05	0.000293	CcSEcCtD
Risperidone—Bronchitis—Topiramate—obesity	3e-05	0.000293	CcSEcCtD
Risperidone—Loss of consciousness—Bupropion—obesity	2.99e-05	0.000293	CcSEcCtD
Risperidone—Abdominal discomfort—Topiramate—obesity	2.99e-05	0.000292	CcSEcCtD
Risperidone—Insomnia—Orlistat—obesity	2.98e-05	0.000291	CcSEcCtD
Risperidone—Hypotension—Sibutramine—obesity	2.98e-05	0.000291	CcSEcCtD
Risperidone—Cough—Bupropion—obesity	2.97e-05	0.000291	CcSEcCtD
Risperidone—Paraesthesia—Orlistat—obesity	2.96e-05	0.000289	CcSEcCtD
Risperidone—Convulsion—Bupropion—obesity	2.95e-05	0.000288	CcSEcCtD
Risperidone—Hypertension—Bupropion—obesity	2.94e-05	0.000287	CcSEcCtD
Risperidone—Neutropenia—Topiramate—obesity	2.91e-05	0.000285	CcSEcCtD
Risperidone—Dysuria—Topiramate—obesity	2.91e-05	0.000285	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Sibutramine—obesity	2.91e-05	0.000284	CcSEcCtD
Risperidone—Dyspepsia—Orlistat—obesity	2.9e-05	0.000284	CcSEcCtD
Risperidone—Chest pain—Bupropion—obesity	2.9e-05	0.000283	CcSEcCtD
Risperidone—Myalgia—Bupropion—obesity	2.9e-05	0.000283	CcSEcCtD
Risperidone—Arthralgia—Bupropion—obesity	2.9e-05	0.000283	CcSEcCtD
Risperidone—Upper respiratory tract infection—Topiramate—obesity	2.89e-05	0.000283	CcSEcCtD
Risperidone—Anxiety—Bupropion—obesity	2.89e-05	0.000282	CcSEcCtD
Risperidone—Insomnia—Sibutramine—obesity	2.88e-05	0.000282	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	2.88e-05	0.000282	CcSEcCtD
Risperidone—Pollakiuria—Topiramate—obesity	2.88e-05	0.000281	CcSEcCtD
Risperidone—Erectile dysfunction—Topiramate—obesity	2.87e-05	0.00028	CcSEcCtD
Risperidone—Discomfort—Bupropion—obesity	2.87e-05	0.00028	CcSEcCtD
Risperidone—Decreased appetite—Orlistat—obesity	2.86e-05	0.00028	CcSEcCtD
Risperidone—Paraesthesia—Sibutramine—obesity	2.86e-05	0.00028	CcSEcCtD
Risperidone—Gastrointestinal disorder—Orlistat—obesity	2.84e-05	0.000278	CcSEcCtD
Risperidone—Dyspnoea—Sibutramine—obesity	2.84e-05	0.000278	CcSEcCtD
Risperidone—Photosensitivity reaction—Topiramate—obesity	2.84e-05	0.000278	CcSEcCtD
Risperidone—Fatigue—Orlistat—obesity	2.84e-05	0.000278	CcSEcCtD
Risperidone—Dry mouth—Bupropion—obesity	2.84e-05	0.000277	CcSEcCtD
Risperidone—Somnolence—Sibutramine—obesity	2.84e-05	0.000277	CcSEcCtD
Risperidone—Weight increased—Topiramate—obesity	2.83e-05	0.000277	CcSEcCtD
Risperidone—Weight decreased—Topiramate—obesity	2.82e-05	0.000275	CcSEcCtD
Risperidone—Pain—Orlistat—obesity	2.82e-05	0.000275	CcSEcCtD
Risperidone—Hyperglycaemia—Topiramate—obesity	2.81e-05	0.000275	CcSEcCtD
Risperidone—Dyspepsia—Sibutramine—obesity	2.81e-05	0.000274	CcSEcCtD
Risperidone—Confusional state—Bupropion—obesity	2.8e-05	0.000274	CcSEcCtD
Risperidone—Pneumonia—Topiramate—obesity	2.79e-05	0.000273	CcSEcCtD
Risperidone—Anaphylactic shock—Bupropion—obesity	2.78e-05	0.000272	CcSEcCtD
Risperidone—Oedema—Bupropion—obesity	2.78e-05	0.000272	CcSEcCtD
Risperidone—Infestation NOS—Topiramate—obesity	2.78e-05	0.000271	CcSEcCtD
Risperidone—Infestation—Topiramate—obesity	2.78e-05	0.000271	CcSEcCtD
Risperidone—Decreased appetite—Sibutramine—obesity	2.77e-05	0.000271	CcSEcCtD
Risperidone—Depression—Topiramate—obesity	2.77e-05	0.000271	CcSEcCtD
Risperidone—Infection—Bupropion—obesity	2.76e-05	0.00027	CcSEcCtD
Risperidone—Stevens-Johnson syndrome—Topiramate—obesity	2.75e-05	0.000269	CcSEcCtD
Risperidone—Gastrointestinal disorder—Sibutramine—obesity	2.75e-05	0.000269	CcSEcCtD
Risperidone—Shock—Bupropion—obesity	2.74e-05	0.000267	CcSEcCtD
Risperidone—Renal failure—Topiramate—obesity	2.73e-05	0.000267	CcSEcCtD
Risperidone—Constipation—Sibutramine—obesity	2.73e-05	0.000267	CcSEcCtD
Risperidone—Pain—Sibutramine—obesity	2.73e-05	0.000267	CcSEcCtD
Risperidone—Nervous system disorder—Bupropion—obesity	2.73e-05	0.000266	CcSEcCtD
Risperidone—Neuropathy peripheral—Topiramate—obesity	2.72e-05	0.000266	CcSEcCtD
Risperidone—Thrombocytopenia—Bupropion—obesity	2.72e-05	0.000266	CcSEcCtD
Risperidone—Feeling abnormal—Orlistat—obesity	2.72e-05	0.000265	CcSEcCtD
Risperidone—Tachycardia—Bupropion—obesity	2.71e-05	0.000265	CcSEcCtD
Risperidone—Stomatitis—Topiramate—obesity	2.71e-05	0.000265	CcSEcCtD
Risperidone—Skin disorder—Bupropion—obesity	2.7e-05	0.000264	CcSEcCtD
Risperidone—Urinary tract infection—Topiramate—obesity	2.7e-05	0.000264	CcSEcCtD
Risperidone—Conjunctivitis—Topiramate—obesity	2.7e-05	0.000264	CcSEcCtD
Risperidone—Gastrointestinal pain—Orlistat—obesity	2.69e-05	0.000263	CcSEcCtD
Risperidone—Hyperhidrosis—Bupropion—obesity	2.69e-05	0.000263	CcSEcCtD
Risperidone—Anorexia—Bupropion—obesity	2.65e-05	0.000259	CcSEcCtD
Risperidone—Haematuria—Topiramate—obesity	2.65e-05	0.000259	CcSEcCtD
Risperidone—Feeling abnormal—Sibutramine—obesity	2.63e-05	0.000257	CcSEcCtD
Risperidone—Epistaxis—Topiramate—obesity	2.62e-05	0.000256	CcSEcCtD
Risperidone—Urticaria—Orlistat—obesity	2.62e-05	0.000256	CcSEcCtD
Risperidone—Gastrointestinal pain—Sibutramine—obesity	2.61e-05	0.000255	CcSEcCtD
Risperidone—Sinusitis—Topiramate—obesity	2.61e-05	0.000255	CcSEcCtD
Risperidone—Body temperature increased—Orlistat—obesity	2.6e-05	0.000255	CcSEcCtD
Risperidone—Abdominal pain—Orlistat—obesity	2.6e-05	0.000255	CcSEcCtD
Risperidone—Hypotension—Bupropion—obesity	2.6e-05	0.000254	CcSEcCtD
Risperidone—Agranulocytosis—Topiramate—obesity	2.59e-05	0.000253	CcSEcCtD
Risperidone—Bradycardia—Topiramate—obesity	2.54e-05	0.000248	CcSEcCtD
Risperidone—Urticaria—Sibutramine—obesity	2.53e-05	0.000248	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Bupropion—obesity	2.53e-05	0.000248	CcSEcCtD
Risperidone—Abdominal pain—Sibutramine—obesity	2.52e-05	0.000246	CcSEcCtD
Risperidone—Body temperature increased—Sibutramine—obesity	2.52e-05	0.000246	CcSEcCtD
Risperidone—Insomnia—Bupropion—obesity	2.51e-05	0.000246	CcSEcCtD
Risperidone—Haemoglobin—Topiramate—obesity	2.51e-05	0.000245	CcSEcCtD
Risperidone—Rhinitis—Topiramate—obesity	2.5e-05	0.000244	CcSEcCtD
Risperidone—Paraesthesia—Bupropion—obesity	2.5e-05	0.000244	CcSEcCtD
Risperidone—Hepatitis—Topiramate—obesity	2.49e-05	0.000244	CcSEcCtD
Risperidone—Haemorrhage—Topiramate—obesity	2.49e-05	0.000244	CcSEcCtD
Risperidone—Hypoaesthesia—Topiramate—obesity	2.48e-05	0.000242	CcSEcCtD
Risperidone—Dyspnoea—Bupropion—obesity	2.48e-05	0.000242	CcSEcCtD
Risperidone—Pharyngitis—Topiramate—obesity	2.47e-05	0.000242	CcSEcCtD
Risperidone—Somnolence—Bupropion—obesity	2.47e-05	0.000242	CcSEcCtD
Risperidone—Urinary tract disorder—Topiramate—obesity	2.46e-05	0.000241	CcSEcCtD
Risperidone—Oedema peripheral—Topiramate—obesity	2.46e-05	0.00024	CcSEcCtD
Risperidone—Connective tissue disorder—Topiramate—obesity	2.45e-05	0.000239	CcSEcCtD
Risperidone—Dyspepsia—Bupropion—obesity	2.45e-05	0.000239	CcSEcCtD
Risperidone—Urethral disorder—Topiramate—obesity	2.44e-05	0.000239	CcSEcCtD
Risperidone—Hypersensitivity—Orlistat—obesity	2.43e-05	0.000237	CcSEcCtD
Risperidone—Decreased appetite—Bupropion—obesity	2.42e-05	0.000236	CcSEcCtD
Risperidone—Visual impairment—Topiramate—obesity	2.4e-05	0.000235	CcSEcCtD
Risperidone—Gastrointestinal disorder—Bupropion—obesity	2.4e-05	0.000235	CcSEcCtD
Risperidone—Fatigue—Bupropion—obesity	2.4e-05	0.000234	CcSEcCtD
Risperidone—Constipation—Bupropion—obesity	2.38e-05	0.000232	CcSEcCtD
Risperidone—Pain—Bupropion—obesity	2.38e-05	0.000232	CcSEcCtD
Risperidone—Asthenia—Orlistat—obesity	2.36e-05	0.000231	CcSEcCtD
Risperidone—Erythema multiforme—Topiramate—obesity	2.36e-05	0.00023	CcSEcCtD
Risperidone—Hypersensitivity—Sibutramine—obesity	2.35e-05	0.00023	CcSEcCtD
Risperidone—Pruritus—Orlistat—obesity	2.33e-05	0.000228	CcSEcCtD
Risperidone—Eye disorder—Topiramate—obesity	2.33e-05	0.000228	CcSEcCtD
Risperidone—Tinnitus—Topiramate—obesity	2.32e-05	0.000227	CcSEcCtD
Risperidone—Cardiac disorder—Topiramate—obesity	2.31e-05	0.000226	CcSEcCtD
Risperidone—Flushing—Topiramate—obesity	2.31e-05	0.000226	CcSEcCtD
Risperidone—Feeling abnormal—Bupropion—obesity	2.29e-05	0.000224	CcSEcCtD
Risperidone—Asthenia—Sibutramine—obesity	2.29e-05	0.000224	CcSEcCtD
Risperidone—Gastrointestinal pain—Bupropion—obesity	2.27e-05	0.000222	CcSEcCtD
Risperidone—Angiopathy—Topiramate—obesity	2.26e-05	0.000221	CcSEcCtD
Risperidone—Pruritus—Sibutramine—obesity	2.26e-05	0.000221	CcSEcCtD
Risperidone—Diarrhoea—Orlistat—obesity	2.25e-05	0.00022	CcSEcCtD
Risperidone—Immune system disorder—Topiramate—obesity	2.25e-05	0.00022	CcSEcCtD
Risperidone—Mediastinal disorder—Topiramate—obesity	2.25e-05	0.00022	CcSEcCtD
Risperidone—Chills—Topiramate—obesity	2.24e-05	0.000219	CcSEcCtD
Risperidone—Urticaria—Bupropion—obesity	2.21e-05	0.000216	CcSEcCtD
Risperidone—Alopecia—Topiramate—obesity	2.2e-05	0.000215	CcSEcCtD
Risperidone—Abdominal pain—Bupropion—obesity	2.2e-05	0.000215	CcSEcCtD
Risperidone—Body temperature increased—Bupropion—obesity	2.2e-05	0.000215	CcSEcCtD
Risperidone—Mental disorder—Topiramate—obesity	2.18e-05	0.000213	CcSEcCtD
Risperidone—Diarrhoea—Sibutramine—obesity	2.18e-05	0.000213	CcSEcCtD
Risperidone—Dizziness—Orlistat—obesity	2.18e-05	0.000213	CcSEcCtD
Risperidone—Erythema—Topiramate—obesity	2.17e-05	0.000212	CcSEcCtD
Risperidone—Malnutrition—Topiramate—obesity	2.17e-05	0.000212	CcSEcCtD
Risperidone—Flatulence—Topiramate—obesity	2.14e-05	0.000209	CcSEcCtD
Risperidone—Tension—Topiramate—obesity	2.13e-05	0.000208	CcSEcCtD
Risperidone—Dysgeusia—Topiramate—obesity	2.13e-05	0.000208	CcSEcCtD
Risperidone—Dizziness—Sibutramine—obesity	2.11e-05	0.000206	CcSEcCtD
Risperidone—Nervousness—Topiramate—obesity	2.11e-05	0.000206	CcSEcCtD
Risperidone—Back pain—Topiramate—obesity	2.1e-05	0.000205	CcSEcCtD
Risperidone—Vomiting—Orlistat—obesity	2.1e-05	0.000205	CcSEcCtD
Risperidone—Muscle spasms—Topiramate—obesity	2.09e-05	0.000204	CcSEcCtD
Risperidone—Rash—Orlistat—obesity	2.08e-05	0.000203	CcSEcCtD
Risperidone—Dermatitis—Orlistat—obesity	2.08e-05	0.000203	CcSEcCtD
Risperidone—Headache—Orlistat—obesity	2.06e-05	0.000202	CcSEcCtD
Risperidone—Hypersensitivity—Bupropion—obesity	2.05e-05	0.0002	CcSEcCtD
Risperidone—Vision blurred—Topiramate—obesity	2.05e-05	0.0002	CcSEcCtD
Risperidone—Tremor—Topiramate—obesity	2.03e-05	0.000199	CcSEcCtD
Risperidone—Vomiting—Sibutramine—obesity	2.03e-05	0.000198	CcSEcCtD
Risperidone—Ill-defined disorder—Topiramate—obesity	2.01e-05	0.000197	CcSEcCtD
Risperidone—Rash—Sibutramine—obesity	2.01e-05	0.000197	CcSEcCtD
Risperidone—Dermatitis—Sibutramine—obesity	2.01e-05	0.000196	CcSEcCtD
Risperidone—Anaemia—Topiramate—obesity	2.01e-05	0.000196	CcSEcCtD
Risperidone—Headache—Sibutramine—obesity	2e-05	0.000195	CcSEcCtD
Risperidone—Asthenia—Bupropion—obesity	1.99e-05	0.000195	CcSEcCtD
Risperidone—Agitation—Topiramate—obesity	1.99e-05	0.000195	CcSEcCtD
Risperidone—Pruritus—Bupropion—obesity	1.97e-05	0.000192	CcSEcCtD
Risperidone—Nausea—Orlistat—obesity	1.96e-05	0.000191	CcSEcCtD
Risperidone—Malaise—Topiramate—obesity	1.96e-05	0.000191	CcSEcCtD
Risperidone—Vertigo—Topiramate—obesity	1.95e-05	0.000191	CcSEcCtD
Risperidone—Syncope—Topiramate—obesity	1.95e-05	0.00019	CcSEcCtD
Risperidone—Leukopenia—Topiramate—obesity	1.94e-05	0.00019	CcSEcCtD
Risperidone—Palpitations—Topiramate—obesity	1.92e-05	0.000187	CcSEcCtD
Risperidone—Loss of consciousness—Topiramate—obesity	1.91e-05	0.000186	CcSEcCtD
Risperidone—Diarrhoea—Bupropion—obesity	1.9e-05	0.000186	CcSEcCtD
Risperidone—Nausea—Sibutramine—obesity	1.89e-05	0.000185	CcSEcCtD
Risperidone—Cough—Topiramate—obesity	1.89e-05	0.000185	CcSEcCtD
Risperidone—Convulsion—Topiramate—obesity	1.88e-05	0.000184	CcSEcCtD
Risperidone—Hypertension—Topiramate—obesity	1.87e-05	0.000183	CcSEcCtD
Risperidone—Arthralgia—Topiramate—obesity	1.85e-05	0.000181	CcSEcCtD
Risperidone—Chest pain—Topiramate—obesity	1.85e-05	0.000181	CcSEcCtD
Risperidone—Myalgia—Topiramate—obesity	1.85e-05	0.000181	CcSEcCtD
Risperidone—Anxiety—Topiramate—obesity	1.84e-05	0.00018	CcSEcCtD
Risperidone—Dizziness—Bupropion—obesity	1.84e-05	0.00018	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	1.84e-05	0.000179	CcSEcCtD
Risperidone—Discomfort—Topiramate—obesity	1.83e-05	0.000178	CcSEcCtD
Risperidone—Dry mouth—Topiramate—obesity	1.81e-05	0.000177	CcSEcCtD
Risperidone—Confusional state—Topiramate—obesity	1.79e-05	0.000175	CcSEcCtD
Risperidone—Oedema—Topiramate—obesity	1.77e-05	0.000173	CcSEcCtD
Risperidone—Vomiting—Bupropion—obesity	1.77e-05	0.000173	CcSEcCtD
Risperidone—Infection—Topiramate—obesity	1.76e-05	0.000172	CcSEcCtD
Risperidone—Rash—Bupropion—obesity	1.75e-05	0.000171	CcSEcCtD
Risperidone—Dermatitis—Bupropion—obesity	1.75e-05	0.000171	CcSEcCtD
Risperidone—Shock—Topiramate—obesity	1.74e-05	0.00017	CcSEcCtD
Risperidone—Headache—Bupropion—obesity	1.74e-05	0.00017	CcSEcCtD
Risperidone—Nervous system disorder—Topiramate—obesity	1.74e-05	0.00017	CcSEcCtD
Risperidone—Thrombocytopenia—Topiramate—obesity	1.73e-05	0.00017	CcSEcCtD
Risperidone—Tachycardia—Topiramate—obesity	1.73e-05	0.000169	CcSEcCtD
Risperidone—Skin disorder—Topiramate—obesity	1.72e-05	0.000168	CcSEcCtD
Risperidone—Hyperhidrosis—Topiramate—obesity	1.71e-05	0.000167	CcSEcCtD
Risperidone—Anorexia—Topiramate—obesity	1.69e-05	0.000165	CcSEcCtD
Risperidone—Hypotension—Topiramate—obesity	1.66e-05	0.000162	CcSEcCtD
Risperidone—Nausea—Bupropion—obesity	1.65e-05	0.000161	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Topiramate—obesity	1.61e-05	0.000158	CcSEcCtD
Risperidone—Insomnia—Topiramate—obesity	1.6e-05	0.000157	CcSEcCtD
Risperidone—Paraesthesia—Topiramate—obesity	1.59e-05	0.000155	CcSEcCtD
Risperidone—Dyspnoea—Topiramate—obesity	1.58e-05	0.000154	CcSEcCtD
Risperidone—Somnolence—Topiramate—obesity	1.57e-05	0.000154	CcSEcCtD
Risperidone—Dyspepsia—Topiramate—obesity	1.56e-05	0.000152	CcSEcCtD
Risperidone—Decreased appetite—Topiramate—obesity	1.54e-05	0.00015	CcSEcCtD
Risperidone—Gastrointestinal disorder—Topiramate—obesity	1.53e-05	0.000149	CcSEcCtD
Risperidone—Fatigue—Topiramate—obesity	1.53e-05	0.000149	CcSEcCtD
Risperidone—Pain—Topiramate—obesity	1.51e-05	0.000148	CcSEcCtD
Risperidone—Constipation—Topiramate—obesity	1.51e-05	0.000148	CcSEcCtD
Risperidone—Feeling abnormal—Topiramate—obesity	1.46e-05	0.000143	CcSEcCtD
Risperidone—Gastrointestinal pain—Topiramate—obesity	1.45e-05	0.000142	CcSEcCtD
Risperidone—Urticaria—Topiramate—obesity	1.41e-05	0.000138	CcSEcCtD
Risperidone—Abdominal pain—Topiramate—obesity	1.4e-05	0.000137	CcSEcCtD
Risperidone—Body temperature increased—Topiramate—obesity	1.4e-05	0.000137	CcSEcCtD
Risperidone—Hypersensitivity—Topiramate—obesity	1.31e-05	0.000128	CcSEcCtD
Risperidone—Asthenia—Topiramate—obesity	1.27e-05	0.000124	CcSEcCtD
Risperidone—Pruritus—Topiramate—obesity	1.25e-05	0.000122	CcSEcCtD
Risperidone—Diarrhoea—Topiramate—obesity	1.21e-05	0.000118	CcSEcCtD
Risperidone—Dizziness—Topiramate—obesity	1.17e-05	0.000114	CcSEcCtD
Risperidone—Vomiting—Topiramate—obesity	1.13e-05	0.00011	CcSEcCtD
Risperidone—Rash—Topiramate—obesity	1.12e-05	0.000109	CcSEcCtD
Risperidone—Dermatitis—Topiramate—obesity	1.12e-05	0.000109	CcSEcCtD
Risperidone—Headache—Topiramate—obesity	1.11e-05	0.000108	CcSEcCtD
Risperidone—Nausea—Topiramate—obesity	1.05e-05	0.000103	CcSEcCtD
Risperidone—HTR2A—Signaling Pathways—NOS3—obesity	6.05e-07	8.16e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—PIK3R1—obesity	6.05e-07	8.16e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—PIK3R1—obesity	6.04e-07	8.15e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—NOS3—obesity	6.04e-07	8.15e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TYK2—obesity	6.03e-07	8.14e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PPARA—obesity	6.03e-07	8.14e-06	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PIK3R1—obesity	6.03e-07	8.14e-06	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—NOS3—obesity	6.03e-07	8.14e-06	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—PTGS2—obesity	6.02e-07	8.12e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—CAV1—obesity	6.02e-07	8.12e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—APOA1—obesity	6e-07	8.1e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CYP2E1—obesity	6e-07	8.1e-06	CbGpPWpGaD
Risperidone—HTR1A—GPCR downstream signaling—AKT1—obesity	6e-07	8.1e-06	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—MYC—obesity	5.99e-07	8.09e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—RHOA—obesity	5.98e-07	8.08e-06	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—TGFB1—obesity	5.98e-07	8.07e-06	CbGpPWpGaD
Risperidone—HTR2C—GPCR downstream signaling—AKT1—obesity	5.97e-07	8.06e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—NQO1—obesity	5.93e-07	8.01e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—NOS3—obesity	5.92e-07	7.99e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—PIK3R1—obesity	5.92e-07	7.99e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—IL6—obesity	5.91e-07	7.97e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—IL6—obesity	5.87e-07	7.93e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—PIK3CA—obesity	5.86e-07	7.9e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—AGT—obesity	5.84e-07	7.88e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—PIK3CD—obesity	5.83e-07	7.87e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MMP9—obesity	5.82e-07	7.85e-06	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—STAT3—obesity	5.81e-07	7.84e-06	CbGpPWpGaD
Risperidone—ADRA2C—GPCR downstream signaling—AKT1—obesity	5.81e-07	7.84e-06	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—PIK3CA—obesity	5.77e-07	7.79e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—SERPINE1—obesity	5.76e-07	7.78e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—PIK3CA—obesity	5.76e-07	7.78e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—PIK3CA—obesity	5.75e-07	7.76e-06	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—STAT3—obesity	5.73e-07	7.73e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—APOE—obesity	5.72e-07	7.73e-06	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—MYC—obesity	5.72e-07	7.72e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—IL6—obesity	5.71e-07	7.71e-06	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—AKT1—obesity	5.71e-07	7.71e-06	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TGFB1—obesity	5.71e-07	7.71e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GCG—obesity	5.69e-07	7.68e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—SLC2A4—obesity	5.69e-07	7.68e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—PIK3CB—obesity	5.67e-07	7.66e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MTOR—obesity	5.67e-07	7.66e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—CAV1—obesity	5.67e-07	7.65e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MAPK8—obesity	5.66e-07	7.64e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—APOA1—obesity	5.66e-07	7.64e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—AKT1—obesity	5.64e-07	7.62e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—PIK3CA—obesity	5.64e-07	7.61e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—IL6—obesity	5.62e-07	7.59e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MMP9—obesity	5.62e-07	7.58e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CYCS—obesity	5.62e-07	7.58e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TYK2—obesity	5.61e-07	7.57e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MMP9—obesity	5.59e-07	7.54e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MTOR—obesity	5.58e-07	7.54e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—PIK3CB—obesity	5.58e-07	7.54e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—PIK3CB—obesity	5.57e-07	7.52e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MTOR—obesity	5.57e-07	7.52e-06	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PIK3CB—obesity	5.57e-07	7.51e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—RHOA—obesity	5.56e-07	7.5e-06	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PTGS2—obesity	5.52e-07	7.44e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GGT1—obesity	5.51e-07	7.44e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GOT1—obesity	5.51e-07	7.44e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—PIK3R1—obesity	5.5e-07	7.43e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—NOS3—obesity	5.5e-07	7.43e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PIK3CG—obesity	5.48e-07	7.4e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—PIK3CB—obesity	5.47e-07	7.38e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MTOR—obesity	5.47e-07	7.38e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MAPK8—obesity	5.46e-07	7.37e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—AKT1—obesity	5.45e-07	7.35e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MMP9—obesity	5.44e-07	7.34e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MAPK8—obesity	5.43e-07	7.34e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—NCOA1—obesity	5.43e-07	7.33e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—AKT1—obesity	5.42e-07	7.32e-06	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—MYC—obesity	5.4e-07	7.28e-06	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TGFB1—obesity	5.38e-07	7.27e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MMP9—obesity	5.35e-07	7.22e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—STK11—obesity	5.35e-07	7.22e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CYP19A1—obesity	5.35e-07	7.22e-06	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—MYC—obesity	5.32e-07	7.19e-06	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—PIK3CA—obesity	5.32e-07	7.18e-06	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TGFB1—obesity	5.31e-07	7.17e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PPARG—obesity	5.29e-07	7.14e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MAPK8—obesity	5.29e-07	7.13e-06	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—PIK3CA—obesity	5.28e-07	7.13e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—AKT1—obesity	5.27e-07	7.12e-06	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—AKT1—obesity	5.27e-07	7.11e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—PIK3CA—obesity	5.24e-07	7.07e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—POMC—obesity	5.22e-07	7.04e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MAPK8—obesity	5.2e-07	7.02e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—INS—obesity	5.19e-07	7e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—AKT1—obesity	5.19e-07	7e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—IL6—obesity	5.18e-07	7e-06	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—AKT1—obesity	5.18e-07	7e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—STAT3—obesity	5.17e-07	6.98e-06	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—AKT1—obesity	5.17e-07	6.98e-06	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—PIK3CA—obesity	5.17e-07	6.98e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PIK3CG—obesity	5.17e-07	6.97e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—IL6—obesity	5.1e-07	6.89e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—IL6—obesity	5.09e-07	6.87e-06	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—PIK3CA—obesity	5.09e-07	6.87e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—PIK3CB—obesity	5.08e-07	6.86e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MTOR—obesity	5.08e-07	6.86e-06	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—AKT1—obesity	5.07e-07	6.85e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—IL6—obesity	5e-07	6.74e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—STAT3—obesity	4.99e-07	6.74e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PPARG—obesity	4.99e-07	6.73e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—COMT—obesity	4.97e-07	6.71e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—STAT3—obesity	4.97e-07	6.71e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MMP9—obesity	4.93e-07	6.66e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—POMC—obesity	4.92e-07	6.64e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PPARGC1A—obesity	4.9e-07	6.62e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GNB3—obesity	4.9e-07	6.62e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—INS—obesity	4.89e-07	6.6e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—HMOX1—obesity	4.88e-07	6.59e-06	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—PIK3CA—obesity	4.86e-07	6.56e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MMP9—obesity	4.85e-07	6.55e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MMP9—obesity	4.84e-07	6.54e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—STAT3—obesity	4.83e-07	6.52e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PIK3CD—obesity	4.82e-07	6.5e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MYC—obesity	4.81e-07	6.49e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MAPK8—obesity	4.8e-07	6.47e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TGFB1—obesity	4.8e-07	6.47e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—AKT1—obesity	4.78e-07	6.46e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GNAS—obesity	4.77e-07	6.44e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—ALB—obesity	4.76e-07	6.42e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—STAT3—obesity	4.76e-07	6.42e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MMP9—obesity	4.75e-07	6.41e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MAPK8—obesity	4.72e-07	6.37e-06	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—AKT1—obesity	4.72e-07	6.36e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MAPK8—obesity	4.71e-07	6.36e-06	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—IL6—obesity	4.71e-07	6.35e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—AKT1—obesity	4.71e-07	6.35e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—AKT1—obesity	4.7e-07	6.34e-06	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—PIK3CA—obesity	4.69e-07	6.34e-06	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—IL6—obesity	4.68e-07	6.31e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—APOB—obesity	4.68e-07	6.31e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—IL6—obesity	4.64e-07	6.26e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MYC—obesity	4.64e-07	6.26e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TGFB1—obesity	4.63e-07	6.25e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MAPK8—obesity	4.62e-07	6.24e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MYC—obesity	4.62e-07	6.23e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—AKT1—obesity	4.61e-07	6.22e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TGFB1—obesity	4.61e-07	6.22e-06	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—PIK3CA—obesity	4.58e-07	6.18e-06	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—IL6—obesity	4.58e-07	6.18e-06	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—PIK3CA—obesity	4.56e-07	6.15e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PIK3R1—obesity	4.55e-07	6.14e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—NOS3—obesity	4.55e-07	6.14e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PIK3CD—obesity	4.54e-07	6.13e-06	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—PIK3CA—obesity	4.52e-07	6.1e-06	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—IL6—obesity	4.51e-07	6.08e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MYC—obesity	4.49e-07	6.06e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—ALB—obesity	4.48e-07	6.05e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TGFB1—obesity	4.48e-07	6.05e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—LPL—obesity	4.46e-07	6.03e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MYC—obesity	4.42e-07	5.97e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MMP9—obesity	4.41e-07	5.96e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TGFB1—obesity	4.41e-07	5.95e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—STAT3—obesity	4.38e-07	5.92e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GPX1—obesity	4.36e-07	5.88e-06	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—AKT1—obesity	4.34e-07	5.86e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—STAT3—obesity	4.31e-07	5.82e-06	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—AKT1—obesity	4.31e-07	5.82e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—STAT3—obesity	4.31e-07	5.81e-06	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—IL6—obesity	4.3e-07	5.81e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MAPK8—obesity	4.29e-07	5.8e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—NOS3—obesity	4.29e-07	5.79e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PIK3R1—obesity	4.29e-07	5.79e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—AKT1—obesity	4.28e-07	5.78e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CD36—obesity	4.24e-07	5.73e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—STAT3—obesity	4.22e-07	5.7e-06	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—AKT1—obesity	4.22e-07	5.7e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PIK3CB—obesity	4.2e-07	5.67e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PTGS2—obesity	4.16e-07	5.62e-06	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—AKT1—obesity	4.16e-07	5.61e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—PIK3CA—obesity	4.08e-07	5.51e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MYC—obesity	4.07e-07	5.5e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TGFB1—obesity	4.06e-07	5.49e-06	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—IL6—obesity	4.06e-07	5.48e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—MTHFR—obesity	4.02e-07	5.43e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MYC—obesity	4.01e-07	5.41e-06	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—IL6—obesity	4e-07	5.4e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MYC—obesity	4e-07	5.4e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TGFB1—obesity	4e-07	5.4e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TGFB1—obesity	3.99e-07	5.39e-06	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—AKT1—obesity	3.97e-07	5.36e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PIK3CB—obesity	3.96e-07	5.34e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PPARA—obesity	3.94e-07	5.32e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—PIK3CA—obesity	3.94e-07	5.32e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MYC—obesity	3.93e-07	5.3e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—STAT3—obesity	3.93e-07	5.3e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PTGS2—obesity	3.92e-07	5.29e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—PIK3CA—obesity	3.92e-07	5.29e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TGFB1—obesity	3.92e-07	5.29e-06	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—AKT1—obesity	3.83e-07	5.18e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—AGT—obesity	3.82e-07	5.16e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—PIK3CA—obesity	3.81e-07	5.15e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—PIK3CA—obesity	3.75e-07	5.06e-06	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—AKT1—obesity	3.74e-07	5.05e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—APOE—obesity	3.74e-07	5.05e-06	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—AKT1—obesity	3.72e-07	5.03e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CAV1—obesity	3.71e-07	5e-06	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—PIK3CA—obesity	3.7e-07	5e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—APOA1—obesity	3.7e-07	4.99e-06	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—AKT1—obesity	3.69e-07	4.98e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MYC—obesity	3.65e-07	4.92e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TGFB1—obesity	3.64e-07	4.91e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—IL6—obesity	3.61e-07	4.88e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—IL6—obesity	3.49e-07	4.71e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—IL6—obesity	3.47e-07	4.68e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—PIK3CA—obesity	3.46e-07	4.67e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—PIK3CA—obesity	3.4e-07	4.59e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—PIK3CA—obesity	3.4e-07	4.58e-06	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PIK3CA—obesity	3.39e-07	4.58e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PIK3CG—obesity	3.38e-07	4.56e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—IL6—obesity	3.38e-07	4.56e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—AKT1—obesity	3.33e-07	4.5e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—PIK3CA—obesity	3.33e-07	4.5e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—IL6—obesity	3.32e-07	4.48e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PPARG—obesity	3.26e-07	4.4e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—AKT1—obesity	3.22e-07	4.34e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—POMC—obesity	3.21e-07	4.34e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—AKT1—obesity	3.2e-07	4.32e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—INS—obesity	3.2e-07	4.32e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—AKT1—obesity	3.11e-07	4.2e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—PIK3CA—obesity	3.1e-07	4.18e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—AKT1—obesity	3.06e-07	4.14e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IL6—obesity	3.06e-07	4.13e-06	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—AKT1—obesity	3.03e-07	4.08e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IL6—obesity	3.01e-07	4.07e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IL6—obesity	3.01e-07	4.06e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PIK3CD—obesity	2.97e-07	4.01e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IL6—obesity	2.95e-07	3.98e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ALB—obesity	2.93e-07	3.96e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—AKT1—obesity	2.83e-07	3.81e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PIK3R1—obesity	2.8e-07	3.78e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—NOS3—obesity	2.8e-07	3.78e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—AKT1—obesity	2.78e-07	3.75e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—AKT1—obesity	2.77e-07	3.74e-06	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—AKT1—obesity	2.77e-07	3.74e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IL6—obesity	2.74e-07	3.7e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—AKT1—obesity	2.72e-07	3.67e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PIK3CB—obesity	2.59e-07	3.49e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PTGS2—obesity	2.56e-07	3.46e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PIK3CA—obesity	2.56e-07	3.46e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—AKT1—obesity	2.53e-07	3.41e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PIK3CA—obesity	2.41e-07	3.26e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—AKT1—obesity	2.09e-07	2.82e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—AKT1—obesity	1.97e-07	2.66e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PIK3CA—obesity	1.58e-07	2.13e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—AKT1—obesity	1.29e-07	1.74e-06	CbGpPWpGaD
